N/A
N=205
Depression Attention for Women Now (The DAWN Study)
Depressive Disorder
Bottom Line
View on ClinicalTrials.gov: NCT01096316 ↗Enrolled (actual)
205
Serious AEs
1.0%
Results posted
Aug 2014
Primary outcome: Primary: Depression Treatment Outcome — 0.96; 1.33 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Depression Care Management (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- University of Washington
- Primary completion
- May 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Depression Treatment Outcome |
0.96; 1.33 | — |
| PRIMARY Functional Outcome |
3.69; 4.03 | — |
| SECONDARY Quality of Depression Care Indicators |
67; 28 | — |
| SECONDARY Potential Facilitators and Barriers to Sustainability |
— | — |
Summary
Major depressive disorder (MDD) is a common disabling illness that disproportionately affects women, with prevalence rates two times those of men. In addition to suffering, MDD has been shown to have a marked effect on social and vocational functioning, with increased disability, lost productivity, and excess mortality. Women with MDD have an increased prevalence of comorbid anxiety disorders and medical conditions.
Our model of care utilizes a social worker as a depression care manager (DCM) to support both patients and physicians in optimizing care in the OB-GYN clinical setting. This intervention will be compared to usual care for depression.
Eligibility Criteria
Inclusion Criteria
- PHQ-9 score ≥10 for Major Depressive Disorder (with 1 cardinal symptom) and/or ≥10 for Dysthymia (with 1 cardinal symptom)
- MINI confirmation of PHQ-9 diagnoses
- Access to a telephone
- English-speaking
Exclusion Criteria
- High suicide risk (PHQ-9 response)
- ≥2 prior suicide attempts
- Lifetime history of schizophrenia or bipolar disorder (MINI response)
- Substance abuse/dependence within the previous 3 months (CAGE-AID)
- Current severe intimate partner violence
- Currently seeing a psychiatrist
Data sourced from ClinicalTrials.gov (NCT01096316). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.